Clinical Trials
Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced the complete enrollment of PREVENT-19, its pivotal Phase 3 study in the United States and Mexico to evaluate the efficacy, safety and immunogenicity of the companyโs...
Drug Research
Sanofi to provide manufacturing support to Johnson & Johnson for their COVID-19 vaccine to help address global supply demands
Sanofi has entered into an agreement with Janssen Pharmaceutical NV and Janssen Pharmaceuticals, Inc., two of the Janssen Pharmaceutical Companies of Johnson & Johnson, under which Sanofi will support manufacturing of Janssenยดs COVID-19 vaccine in order to address the...
News
Eisai gets Corporate Philanthropy Award for its efforts to realize human health care philosophy
Eisai Co., Ltd. has received the 18th Corporate Philanthropy Award (FY 2020) of the Japan Philanthropic Association. The presentation ceremony was held on last Friday, February 19, 2021 at the GakushiKaikan (Chiyoda-ku, Tokyo).
The Corporate Philanthropy Award was founded in...
News
Gan & Lee Pharma, IDF partner to promote diabetes care and prevention worldwide
Gan & Lee Pharmaceuticals Co Ltd, a global biopharmaceutical company, has announced a Collaborating association with the International Diabetes Federation (IDF) that seeks to support its global effort to promote diabetes care and prevention worldwide. This collaboration will enable...
Drug Research
Lilly and Rigel collaborate to develop RIPK1 inhibitors for potential treatment of immunological and neurodegenerative diseases
Eli Lilly and Company and Rigel Pharmaceuticals, Inc. announced a global exclusive license agreement and strategic collaboration to co-develop and commercialize Rigel's R552, a receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitor, for all indications including autoimmune and inflammatory diseases. Pursuant...
News
China approves 16 home grown Covid-19 vaccines for clinical trials
China has approved clinical trials for 16 indigenous COVID-19 vaccines, of which six are in the third stage, according to a state-run media report.
The latest vaccines for clinical trials are based on recombinant protein, adenovirus vector, nucleic acid and...
News
Serbia gets shipment of AstraZeneca COVID-19 vaccine made in India
A shipment of 150,000 COVID-19 vaccines developed by AstraZeneca and Oxford University arrived at Belgrade airport on Sunday, making Serbia the first country in the Western Balkan region to receive supplies of the shot.
The vaccines, which arrived on a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















